Today

Agents

Chat

Arena

Discover

More

App

Neurocrine Biosciences Q2 Adjusted EPS USD 2.85 Vs. IBES Estimate USD 1.34 - NBIX News | Rallies

Neurocrine Biosciences Q2 Adjusted EPS USD 2.85 Vs. IBES Estimate USD 1.34

NBIX•2026-07-30

Q2 earnings and income results

Jul. 30 (Reuters) - Neurocrine Biosciences Q2 EPS USD 1.39.

Q2 adjusted net income USD 297 million vs. IBES estimate USD 141.4 million
Q2 net income USD 144 million

Related News

Lakeshore Acquisition III extends business-combination deadline to Aug. 1, 2027 under amended charter

LCCC•2026-07-30

Apple falls after Q3 results

AAPL•2026-07-30

Alpine Banks Q2 net income rises as loan balances grow

2026-07-30

Ingram Micro raises quarterly dividend to $0.086 per share

INGM•2026-07-30

Quaker Houghton Q2 adjusted EPS beats estimates, announces $250 mln buyback

KWR•2026-07-30